Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Saint Louis University creates new cancer education, prevention and research center

Saint Louis University (SLU) is creating a new cancer education, prevention and research center to improve the survival of St. Louis minorities - particularly African-American residents of north St. Louis city and county.

10 Sep 2012

UH lecture to explore hormones in health and disease

While estrogen is essential for many of the body's normal processes in both men and women, it also plays a role in diseases such as breast, ovarian and prostate cancer. The impact of this hormone on such diseases will be addressed during a lecture Sept. 25 at the University of Houston (UH).

10 Sep 2012

Race, marital status can impact survival rates of patients with Stage III non-small cell lung cancer

A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient survival rates, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

7 Sep 2012

RSV virus selectively kills cancer cells

RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.

7 Sep 2012

UEA, IFR to study protective effects of broccoli consumption against prostate cancer

The Prostate Cancer Foundation is providing $1M of funding to the Institute of Food Research and the University of East Anglia (UEA) to study the protective effects of broccoli consumption against prostate cancer.

6 Sep 2012

More focus required on hospice care for heart failure patients

End-stage heart failure patients enter hospice care closer to the time of their death, are more often referred from acute care facilities, and are more likely to die in acute care settings compared with cancer patients, show study results.

5 Sep 2012

Fusion-negative prostate tumours display more aberrant DNA methylations

In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until now.

5 Sep 2012

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.

4 Sep 2012

Parkinson disease may share common pathogenic mechanisms with some cancers

A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives, according to a report published Online First by Archives of Neurology, a JAMA Network publication.

4 Sep 2012

Study establishes association of IL-16 with prostate cancer in African-American men

Prostate cancer in African-American men is associated with specific changes in the IL-16 gene, according to researchers at the University of Illinois at Chicago College of Medicine.

1 Sep 2012

Astellas Pharma receives FDA approval for Xtandi to treat metastatic CRPC

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.

1 Sep 2012

GenSpera plans to initiate G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

1 Sep 2012

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen Research & Development, LLC, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for ZYTIGA (abiraterone acetate) administered in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.

30 Aug 2012

Book guides men with prostate cancer to maintain sexual health and quality of life

Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.

30 Aug 2012

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab.

30 Aug 2012

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease.

30 Aug 2012

Physicians’ emotional, institutional barriers prolong medical futility at end of life

The most common reasons that clinicians give to explain medically futile treatment at the end of life are emotional difficulties, such as a fear of talking about death, and institutional barriers, such as hospital departments expecting them to “do everything possible,” report German researchers.

29 Aug 2012

Anova Cancer Care to participate in CyberKnife research study

Anova Cancer Care has been chosen to participate in a landmark national prostate cancer study. The goal of the two-year study is to determine the best treatments for prostate cancer. The study will look specifically at prostate cancer radiosurgery.

29 Aug 2012

Acorda’s GGF2 can improve erectile function after cavernous nerve damage

Acorda Therapeutics, Inc. announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN) injury, a common complication of prostate surgery.

29 Aug 2012

Taking aspirin associated with reduced risk of death from prostate cancer

Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, says a new study that includes a researcher at UT Southwestern Medical Center.

29 Aug 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Saint Louis University creates new cancer education, prevention and research center

UH lecture to explore hormones in health and disease

Race, marital status can impact survival rates of patients with Stage III non-small cell lung cancer

RSV virus selectively kills cancer cells

UEA, IFR to study protective effects of broccoli consumption against prostate cancer

More focus required on hospice care for heart failure patients

Fusion-negative prostate tumours display more aberrant DNA methylations

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

Parkinson disease may share common pathogenic mechanisms with some cancers

Study establishes association of IL-16 with prostate cancer in African-American men

Astellas Pharma receives FDA approval for Xtandi to treat metastatic CRPC

GenSpera plans to initiate G-202 Phase II trial in prostate cancer

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Book guides men with prostate cancer to maintain sexual health and quality of life

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Physicians’ emotional, institutional barriers prolong medical futility at end of life

Anova Cancer Care to participate in CyberKnife research study

Acorda’s GGF2 can improve erectile function after cavernous nerve damage

Taking aspirin associated with reduced risk of death from prostate cancer

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in